' Exorbitant ' Cost of SMA Drug Restricts Kids ' Access ' Exorbitant ' Cost of SMA Drug Restricts Kids ' Access

Bioethicists and clinicians involved in the care of children with SMA are voicing concern over insurers ' limiting reimbursement of nusinersen, which costs up to $750,000 a year.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news